Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02291's Dividend Yield % is ranked better than 88.57% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 1.94
vs HKSE:02291: 5.02
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Lepu Scientech Medical Technology (Shanghai) Co Ltd is 0.89, which seems too high.
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lepu Scientech Medical Technology (Shanghai) Co Dividend Yield % Chart
Lepu Scientech Medical Technology (Shanghai) Co Annual Data
HKSE:02291 vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, Lepu Scientech Medical Technology (Shanghai) Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lepu Scientech Medical Technology (Shanghai) Co Dividend Yield % vs Medical Devices & Instruments Industry
Lepu Scientech Medical Technology (Shanghai) Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Lepu Scientech Medical Technology (Shanghai) Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.572551
2026-05-27
2026-05-29
2026-07-31
Cash Dividend
annually
HKD:HKD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) has a Dividend Yield % of 5.02% as of Aug. 20, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. This is 38% above median its historical median of 3.64. Over the past decade, Lepu Scientech Medical Technology (Shanghai) Co's Dividend Yield % has ranged from 2.39 to 7.84. According to the industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #36 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 11.4%.
Is Lepu Scientech Medical Technology (Shanghai) Co's Dividend Yield % too high?
Lepu Scientech Medical Technology (Shanghai) Co's current Dividend Yield % of 5.02% is 38% above median its 10-year median of 3.64. Over the past 10 years, this metric has ranged from a low of 2.39 to a high of 7.84. The Medical Devices & Instruments industry median Dividend Yield % is 1.94. Lepu Scientech Medical Technology (Shanghai) Co's value of 5.02% is 158.8% above this industry median. Based on the distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #36 out of 315 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lepu Scientech Medical Technology (Shanghai) Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lepu Scientech Medical Technology (Shanghai) Co's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #36 out of 315 companies for Dividend Yield %. This places Lepu Scientech Medical Technology (Shanghai) Co in the top 11% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.94. Lepu Scientech Medical Technology (Shanghai) Co's value of 5.02% is 158.8% above this benchmark. Historically, Lepu Scientech Medical Technology (Shanghai) Co's own Dividend Yield % has ranged from 2.39 to 7.84 over the past decade. While the company's 10-year median is 3.64 vs. the industry median of 1.94, Lepu Scientech Medical Technology (Shanghai) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.94, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lepu Scientech Medical Technology (Shanghai) Co's current Dividend Yield % of 5.02% is 158.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lepu Scientech Medical Technology (Shanghai) Co's current Dividend Yield % is 5.02%, which is 38% above median its own 10-year median of 3.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lepu Scientech Medical Technology (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$44.29, compared to a current price of HK$12.18 — trading 72.5% below its estimated fair value. The current Dividend Yield % is 5.02%, which is 38% above median its 10-year median of 3.64 and 158.8% above the Medical Devices & Instruments industry median of 1.94. Lepu Scientech Medical Technology (Shanghai) Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291), the current Dividend Yield % is 5.02% as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Overvalued in 2026?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co stock appears to be undervalued.
The current stock price of HK$12.18 is trading 72.5% below its estimated GF Value™ of HK$44.29.
GuruFocus considers Lepu Scientech Medical Technology (Shanghai) Co to be Significantly Undervalued.
Key valuation signals for HKSE:02291:
Dividend Yield %: 5.02% (38% above median its 10-year median of 3.64)
GF Value™: HK$44.29 vs. price of HK$12.18 (72.5% below fair value)
Industry Position: 158.8% above the Medical Devices & Instruments median (#36 of 315)
No single metric tells the full story. See the HKSE:02291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
76GF Score
Get the complete analysis for HKSE:02291
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02291 has been successfully added to your 
